shall agree to prepare and submit, not later than 90 days 
after the end of the grant or cooperative agreement period, 
a report to the Secretary describing the results of the ac-
tivities supported through the grant or cooperative agree-
ment. 
(d) AUTHORIZATION
OF APPROPRIATIONS.—There 
are authorized to be appropriated to carry out this section 
$5,000,000 for each of the fiscal years 2014 through 
2018. 
SEC. 5. REDUCING OVERDOSE DEATHS. 
Part J of title III of the Public Health Service Act 
(42 U.S.C. 280b et seq.) is amended by inserting after 
section 393D (42 U.S.C. 280b–1f) the following: 
‘‘SEC. 393F. REDUCING OVERDOSE DEATHS. 
‘‘(a) PREVENTION OF DRUG OVERDOSE.—Not later 
than 180 days after the date of the enactment of this sec-
tion, the Secretary, in consultation with a task force com-
prised of stakeholders, shall develop a plan to reduce the 
number of deaths occurring from overdoses of drugs and 
shall submit the plan to Congress. The plan shall in-
clude— 
‘‘(1) a plan for implementation of a public 
health campaign to educate prescribers and the pub-
lic about overdose prevention and naloxone prescrip-
tion; 
VerDate Mar 15 2010 
00:29 Mar 11, 2014
Jkt 039200
PO 00000
Frm 00013
Fmt 6652
Sfmt 6201
E:\BILLS\H4169.IH
H4169
jbell on DSK7SPTVN1PROD with BILLS
‘‘(2) recommendations for improving and ex-
panding overdose prevention programming; and 
‘‘(3) recommendations for such legislative or 
administrative action as the Secretary considers ap-
propriate. 
‘‘(b) TASK FORCE REPRESENTATION.— 
‘‘(1) REQUIRED MEMBERS.—The task force re-
ferred to in subsection (a) shall include at least one 
representative of each of the following: 
‘‘(A) Individuals directly impacted by drug 
overdose. 
‘‘(B) Direct service providers who engage 
individuals at risk of a drug overdose. 
‘‘(C) Drug overdose prevention advocates. 
‘‘(D) The NIDA. 
‘‘(E) The Center for Substance Abuse 
Treatment. 
‘‘(F) The CDC. 
‘‘(G) The Health Resources and Services 
Administration. 
‘‘(H) The Food and Drug Administration. 
‘‘(I) The Office of National Drug Control 
Policy. 
‘‘(J) The American Medical Association. 
VerDate Mar 15 2010 
00:29 Mar 11, 2014
Jkt 039200
PO 00000
Frm 00014
Fmt 6652
Sfmt 6201
E:\BILLS\H4169.IH
H4169
jbell on DSK7SPTVN1PROD with BILLS
‘‘(K) The American Association of Poison 
Control Centers. 
‘‘(L) The Bureau of Prisons. 
‘‘(M) The Centers for Medicare & Medicaid 
Services. 
‘‘(N) The Department of Justice. 
‘‘(2) ADDITIONAL
MEMBERS.—In addition to 
the representatives required by paragraph (1), the 
task force referred to in subsection (a) may include 
other representatives of individuals or entities with 
expertise relating to drug overdoses.’’. 
SEC. 6. OVERDOSE PREVENTION RESEARCH. 
(a) OVERDOSE RESEARCH.—The Director of the 
NIDA shall prioritize and conduct or support research on 
drug overdose and overdose prevention. The primary aims 
of this research shall include— 
(1) examination of circumstances that con-
tribute to drug overdose and identification of drugs 
associated with fatal overdose; 
(2) evaluation of existing overdose prevention 
methods; 
(3) pilot programs or research trials on new 
overdose prevention strategies or programs that have 
not been studied in the United States; 
VerDate Mar 15 2010 
00:29 Mar 11, 2014
Jkt 039200
PO 00000
Frm 00015
Fmt 6652
Sfmt 6201
E:\BILLS\H4169.IH
H4169
jbell on DSK7SPTVN1PROD with BILLS
(4) scientific research concerning the effective-
ness of overdose prevention programs, including how 
to effectively implement and sustain such programs; 
and 
(5) comparative effectiveness research on over-
dose prevention programs. 
(b) FORMULATIONS OF NALOXONE.—The Director of 
the NIDA shall support research on the development of 
formulations of naloxone and dosage delivery devices spe-
cifically intended to be used by lay persons or first re-
sponders for the prehospital treatment of unintentional 
drug overdose. 
(c) AUTHORIZATION
OF APPROPRIATIONS.—There 
are authorized to be appropriated to carry out this section 
$5,000,000 for each of the fiscal years 2014 through 
2018. 
SEC. 7. OFFSET OF COSTS AND PERSONNEL. 
Notwithstanding any other provision of law, the Sec-
retary shall— 
(1) eliminate such initiatives, positions, and 
programs as the Secretary deems necessary to en-
sure any and all costs incurred to carry out the pro-
visions of this Act, and the amendments made by 
this Act, are entirely offset; 
VerDate Mar 15 2010 
00:29 Mar 11, 2014
Jkt 039200
PO 00000
Frm 00016
Fmt 6652
Sfmt 6201
E:\BILLS\H4169.IH
H4169
jbell on DSK7SPTVN1PROD with BILLS
(2) ensure no net increase in personnel are 
added to carry out the provisions of this Act, with 
any new full- or part-time employees or equivalents 
offset by eliminating an equivalent number of exist-
ing staff; 
(3) not later than 60 days after the date of the 
enactment of this Act, report to the Congress on the 
actions taken to ensure compliance with paragraphs 
(1) and (2), including the specific initiatives, posi-
tions, and programs that have been eliminated to en-
sure that the costs of carrying out this Act will be 
offset; and 
(4) not implement any other provision of this 
Act (other than paragraphs (1), (2), and (3)) or any 
amendment made by this Act until the Secretary has 
certified that the actions specified in paragraphs (1), 
(2), and (3) have been completed. 
SEC. 8. DEFINITIONS. 
In this Act: 
(1) CDC.—The term ‘‘CDC’’ means the Cen-
ters for Disease Control and Prevention. 
(2) DRUG.—The term ‘‘drug’’— 
(A) means a drug (as that term is defined 
in section 201 of the Federal Food, Drug, and 
Cosmetic Act (21 U.S.C. 321)); and 
VerDate Mar 15 2010 
00:29 Mar 11, 2014
Jkt 039200
PO 00000
Frm 00017
Fmt 6652
Sfmt 6201
E:\BILLS\H4169.IH
H4169
jbell on DSK7SPTVN1PROD with BILLS